Article Sidebar

PDF (Tiếng Việt)
Published: 2021-11-01
Abstract Views: 238
Views PDF (Tiếng Việt): 332
DOI: https://doi.org/10.52852/tcncyh.v143i7.649
Issue
Vol. 143 No. 7 (2021)
Section
Các bài báo
How to Cite
Huy, T. L., & Việt, L. (2021). The correlation between serum psa concentration and bone metastasis in prostate cancer . Journal of Medical Research, 143(7), 48-52. https://doi.org/10.52852/tcncyh.v143i7.649

The correlation between serum psa concentration and bone metastasis in prostate cancer

Trịnh Lê Huy, Lê Việt

Main Article Content

Abstract

This is a retrospective, descriptive study of 77 patients with prostate cancer admitted to the Department of Urologic Surgery, National Cancer Hospital. The percentage of patients with PSA concentration > 20 ng/mL was 40.2%. Of 77 patients, the rate of bone metastasis of patients with serum PSA level > 20 ng/mL, PSA 10-20 ng/mL, and PSA < 10ng/mL were 35.1%, 15.5%, and 3.9%, respectively. 42 patients had bone metastasis on bone scintigraphy, 27 of whom had serum PSA level >20 ng/mL (64,2%). Of these 27 patients, most had ≥ 2 bone metastasis (n = 26). There was a correlation between the total PSA concentration and the number of bone lesions on bone scintigraphy with r = 0.63. To sum up, total PSA concentration has prognostic value in bone scintigraphy. Thus, bone scintigraphy should be an indicator for early detection of bone metastasis in prostate cancer patients with high serum PSA level.

Article Details

Keywords

Prostate cancer, PSA concentration, bone metastasis.

References

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209 - 249.
2. Gandaglia G, Abdollah F, Schiffmann J, trudeau V, Shariat SF, Kim SP, Perrotte P, Montorsi F, briganti A, trinh QD, Karakiewicz PI, Sun M. Distribution of metastatic sites in patients with prostate cancer: A population - based analysis. Prostate. 2014 Feb;74(2):210 - 6.
3. Evandro L. de Abreu, benedita A.L. de Abreu (2005). Correlation Between PSA Level, Gleason Score and Bone Scan in Staging of Prostate Cancer Patients.
4. Mai Trọng Khoa, Nguyễn Thị The, trần Đình Hà, Nguyễn Thành Chương và cộng sự (2008). Giá trị của xại hình xương trong phát hiện tổn thương di căn xương trên bệnh nhân ung thư nguyên phát. Tạp chí Y Học lâm sàng.
5. Zaman MU, Fatinma, Sajjad Z (2011) Metastatic on bone scane with low prostate specific antigen (≤ 20ng/mL) and Gleason‘s score ( < 8) in newly diagnosed Pakistani males with prostate cancer: should we follow Western guidelines.
6. Clare C, Royle D, Saharia K, Pearse H, Oxberry S, Oakley K, Allsopp L, Rigby AS, Johnson MJ. Painful bone metastases: a prospective observational cohort study. Palliat Med. 2005 Oct;19(7):521 - 5. doi: 10.1191/0269216305pm1079oa. PMID: 16295283.
7. Schaberg J, Gainor BJ. A profile of metastatic carcinoma of the spine. Spine (Phila Pa 1976). 1985 Jan - Feb;10(1):19 - 20. doi: 10.1097/00007632 - 198501000 - 00003. PMID: 3983700.
8. Lee SH, Chung MS, Park KK, Yom CD, Lee DH, Chung BH. Is it suitable to eliminate bone scan for prostate cancer patients with PSA ≤ 20 ng/mL? World J Urol. 2012;30(2):265 - 269. doi:10.1007/s00345 - 011 - 0728 - 6
9. Begic A, Kucukalic –Selimovic E, Obralic N et al (2006): The relationship between the serum prostate specific antigen and whole body scintigraphy in prostate cancer patients after prostatectomy.